I rate Waste Management a buy due to strong revenue growth, margin expansion, and a valuation discount versus peers. Revenue growth is driven by pricing power, sustainability initiatives, healthcare cross-selling, and bolt-on M&A, with weather headwinds now behind us. Margins should benefit from automation, exiting low-margin contracts, and synergy realization in the healthcare segment, despite near-term dilution.
Waste Management's economic necessity, innovation, and strategic acquisitions position it for sustained growth despite questions about its valuation in a tech-driven economy. The company is expanding in high-growth segments like recycling and renewable energy, investing billions to capture rising demand and enhance sustainability. Recent acquisitions, especially Stericycle, strengthen WM's business model, diversify revenue streams, and support long-term value creation.
Waste Management (WM) closed the most recent trading day at $237.15, moving +1.22% from the previous trading session.
Luton, Bedfordshire, United Kingdom, June 12, 2025 (GLOBE NEWSWIRE) -- The global digital smart waste management solutions market is experiencing transformative growth, with an estimated valuation of USD 5.8 billion in 2024. Driven by technological innovation and increasing demand for sustainable practices, the market is projected to reach nearly USD 12 billion by 2034, expanding at a Compound Annual Growth Rate (CAGR) of 7.5% during the forecast period from 2025 to 2034.
Complete response achieved in CLL; overall objective response rate of 80.9% in CLL patients and 84.2% in patients with WM
The Wood Chipper Machines Market is experiencing robust growth due to the escalating global emphasis on renewable energy sources and sustainable waste management. The Wood Chipper Machines Market is experiencing robust growth due to the escalating global emphasis on renewable energy sources and sustainable waste management.
Waste Management Inc. (NYSE: WM) has a large competitive moat, new market expansion opportunities, and a growing renewable energy business.
Waste Management (WM) concluded the recent trading session at $238.89, signifying a -0.54% move from its prior day's close.
Designation Supported by CLOVER WaM Phase 2 Study Data Which Reported an 83.6% Overall Response Rate (ORR) Seeking Guidance from EMA to Determine if CLOVER WaM Phase 2 Data Meets Criteria to Apply for Fast-Track, Conditional Marketing Authorization, Answer Expected Late July FLORHAM PARK, N.J., June 04, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for iopofosine I 131, a potential first-in-class, novel cancer targeting agent utilizing a phospholipid ether as a radioconjugate monotherapy, for the treatment of relapsed/refractory Waldenstrom macroglobulinemia (r/r WM).
The latest trading day saw Waste Management (WM) settling at $237.76, representing a +0.26% change from its previous close.
Waste Management (WM) reported earnings 30 days ago. What's next for the stock?
When investors search for new trade ideas or potential breakout stocks, only a handful of indicators tend to stand out beyond the typical technical patterns. One of the most valuable comes not from price charts, but from the research and positioning of experienced market participants with the insight and track record to spot real opportunities.